Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Regional consolidation of orthopedic surgery: impacts on hip fracture surgery access and outcomes.

Kreindler SA, Siragusa L, Bohm E, Rudnick W, Metge CJ.

Can J Surg. 2017 Sep;60(5):349-354.

2.

Chronic Obstructive Pulmonary Disease (COPD) Integrated Care Pathway Project: Evaluation of Patient Outcomes and System Efficiencies.

Norrie OS, Dziadekwich R, Fernandez R, Metge CJ.

J Popul Ther Clin Pharmacol. 2016 Sep 13;23(3):e169-e182. doi: 10.22374/1710-6222.23.1.1. No abstract available.

PMID:
27783476
3.

Patient characteristics associated with longer emergency department stay: a rapid review.

Kreindler SA, Cui Y, Metge CJ, Raynard M.

Emerg Med J. 2016 Mar;33(3):194-9. doi: 10.1136/emermed-2015-204913. Epub 2015 Sep 4. Review.

PMID:
26341654
4.

Temporal trends in obesity, osteoporosis treatment, bone mineral density, and fracture rates: a population-based historical cohort study.

Leslie WD, Lix LM, Yogendran MS, Morin SN, Metge CJ, Majumdar SR.

J Bone Miner Res. 2014 Apr;29(4):952-9. doi: 10.1002/jbmr.2099.

5.

Examining the impact of reimbursement on referral to bone density testing for older adults: 8 years of data from the Barwon Statistical Division, Australia.

Brennan SL, Kotowicz MA, Sarah B, Leslie WD, Ebeling PR, Metge CJ, Dobbins AG, Pasco JA.

Arch Osteoporos. 2013;8:152. doi: 10.1007/s11657-013-0152-1. Epub 2013 Sep 27.

PMID:
24072727
6.

Impact of a regional acute care surgery model on patient access and outcomes.

Kreindler SA, Zhang L, Metge CJ, Nason RW, Wright B, Rudnick W, Moffatt ME.

Can J Surg. 2013 Oct;56(5):318-24.

7.

The disconnect between better quality of glucocorticoid-induced osteoporosis preventive care and better outcomes: a population-based cohort study.

Majumdar SR, Lix LM, Morin SN, Yogendran M, Metge CJ, Leslie WD.

J Rheumatol. 2013 Oct;40(10):1736-41. doi: 10.3899/jrheum.130041. Epub 2013 Jul 1.

PMID:
23818715
8.

Movement disorders in elderly users of risperidone and first generation antipsychotic agents: a Canadian population-based study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

PLoS One. 2013 May 16;8(5):e64217. doi: 10.1371/journal.pone.0064217. Print 2013.

9.

Direct healthcare costs for 5 years post-fracture in Canada: a long-term population-based assessment.

Leslie WD, Lix LM, Finlayson GS, Metge CJ, Morin SN, Majumdar SR.

Osteoporos Int. 2013 May;24(5):1697-705. doi: 10.1007/s00198-012-2232-2. Epub 2013 Jan 23. Erratum in: Osteoporos Int. 2013 Nov;24(11):2901.

PMID:
23340947
10.

Adverse events in elderly users of antipsychotic pharmacotherapy in the province of Manitoba: a retrospective cohort study.

Vasilyeva I, Biscontri RG, Enns MW, Metge CJ, Alessi-Severini S.

J Clin Psychopharmacol. 2013 Feb;33(1):24-30. doi: 10.1097/JCP.0b013e31827934a4.

PMID:
23277238
11.

Showing the way: enhance the value of research findings.

Metge CJ.

Res Social Adm Pharm. 2012 Sep-Oct;8(5):357-9. doi: 10.1016/j.sapharm.2012.05.011. No abstract available.

PMID:
22986175
12.

Population-based trends in osteoporosis management after new initiations of long-term systemic glucocorticoids (1998-2008).

Majumdar SR, Lix LM, Yogendran M, Morin SN, Metge CJ, Leslie WD.

J Clin Endocrinol Metab. 2012 Apr;97(4):1236-42. doi: 10.1210/jc.2011-2645. Epub 2012 Feb 1.

PMID:
22298803
13.

Direct costs of fractures in Canada and trends 1996-2006: a population-based cost-of-illness analysis.

Leslie WD, Metge CJ, Azimaee M, Lix LM, Finlayson GS, Morin SN, Caetano P.

J Bone Miner Res. 2011 Oct;26(10):2419-29. doi: 10.1002/jbmr.457.

14.

What comes after producing the evidence? The importance of external validity to translating science to practice.

Metge CJ.

Clin Ther. 2011 May;33(5):578-80. doi: 10.1016/j.clinthera.2011.05.050. No abstract available.

PMID:
21665042
15.

Association of antiepileptic drugs with nontraumatic fractures: a population-based analysis.

Jetté N, Lix LM, Metge CJ, Prior HJ, McChesney J, Leslie WD.

Arch Neurol. 2011 Jan;68(1):107-12. doi: 10.1001/archneurol.2010.341.

PMID:
21220681
16.

Secular decreases in fracture rates 1986-2006 for Manitoba, Canada: a population-based analysis.

Leslie WD, Sadatsafavi M, Lix LM, Azimaee M, Morin S, Metge CJ, Caetano P.

Osteoporos Int. 2011 Jul;22(7):2137-43. doi: 10.1007/s00198-010-1470-4. Epub 2010 Nov 11.

PMID:
21069292
17.

Patient-centered services: what could we be doing right?

Metge CJ.

Clin Ther. 2010 May;32(5):962-4. doi: 10.1016/j.clinthera.2010.05.009. No abstract available.

PMID:
20685504
18.

Fracture risk in androgen deprivation therapy: a Canadian population based analysis.

Lau YK, Lee E, Prior HJ, Lix LM, Metge CJ, Leslie WD.

Can J Urol. 2009 Dec;16(6):4908-14.

PMID:
20003666
19.

Selective serotonin reuptake inhibitors are associated with a modest increase in the risk of upper gastrointestinal bleeding.

Targownik LE, Bolton JM, Metge CJ, Leung S, Sareen J.

Am J Gastroenterol. 2009 Jun;104(6):1475-82. doi: 10.1038/ajg.2009.128. Epub 2009 Apr 28.

PMID:
19491861
20.

Access and intensity of use of prescription analgesics among older Manitobans.

Sadowski CA, Carrie AG, Grymonpre RE, Metge CJ, St John P.

Can J Clin Pharmacol. 2009 Summer;16(2):e322-30. Epub 2009 May 29.

PMID:
19483264
21.

Postfracture care for older women: gaps between optimal care and actual care.

Metge CJ, Leslie WD, Manness LJ, Yogendran M, Yuen CK, Kvern B; Maximizing Osteoporosis Management in Manitoba Steering Committee.

Can Fam Physician. 2008 Sep;54(9):1270-6.

22.

Use of proton pump inhibitors and risk of osteoporosis-related fractures.

Targownik LE, Lix LM, Metge CJ, Prior HJ, Leung S, Leslie WD.

CMAJ. 2008 Aug 12;179(4):319-26. doi: 10.1503/cmaj.071330.

23.

Ethically speaking: issues in the postmarketing evaluation of pharmaceuticals.

Metge CJ.

Clin Ther. 2008 Jul;30(7):1342-4. No abstract available.

PMID:
18691995
24.

Underutilization of gastroprotective strategies in aspirin users at increased risk of upper gastrointestinal complications.

Targownik LE, Metge CJ, Leung S.

Aliment Pharmacol Ther. 2008 Jul;28(1):88-96. doi: 10.1111/j.1365-2036.2008.03713.x. Epub 2008 Apr 13.

25.

The relative efficacies of gastroprotective strategies in chronic users of nonsteroidal anti-inflammatory drugs.

Targownik LE, Metge CJ, Leung S, Chateau DG.

Gastroenterology. 2008 Apr;134(4):937-44. doi: 10.1053/j.gastro.2008.01.010. Epub 2008 Jan 11.

PMID:
18294634
26.
27.

Clinical risk factors for fracture in postmenopausal Canadian women: a population-based prevalence study.

Leslie WD, Anderson WA, Metge CJ, Manness LJ; Maximizing Osteoporosis Management in Manitoba Steering Committee.

Bone. 2007 Apr;40(4):991-6. Epub 2006 Dec 19.

PMID:
17182296
28.

Bone density and bone area in Canadian Aboriginal women: the First Nations Bone Health Study.

Leslie WD, Metge CJ, Weiler HA, Doupe M, Wood Steiman P, O'Neil JD.

Osteoporos Int. 2006 Dec;17(12):1755-62. Epub 2006 Sep 8.

PMID:
16960648
29.
30.

Prognostic value of lung sestamibi uptake in myocardial perfusion imaging of patients with known or suspected coronary artery disease.

Leslie WD, Tully SA, Yogendran MS, Ward LM, Nour KA, Metge CJ.

J Am Coll Cardiol. 2005 May 17;45(10):1676-82.

31.

Prognostic value of automated quantification of 99mTc-sestamibi myocardial perfusion imaging.

Leslie WD, Tully SA, Yogendran MS, Ward LM, Nour KA, Metge CJ.

J Nucl Med. 2005 Feb;46(2):204-11.

32.

Management competencies for Canadian health executives: views from the field.

MacKinnon NJ, Chow C, Kennedy PL, Persaud DD, Metge CJ, Sketris I.

Healthc Manage Forum. 2004 Winter;17(4):15-20, 40-5. English, French.

PMID:
15682593
33.

Predictors of receipt of a fluoroquinolone versus trimethoprim-sulfamethoxazole for treatment of acute pyelonephritis in women in Manitoba, Canada.

Carrie AG, Metge CJ, Collins DM, Harding GK, Zhanel GG.

Pharmacoepidemiol Drug Saf. 2004 Dec;13(12):863-70.

PMID:
15386718
34.

Automated quantification of 99mTc sestamibi myocardial perfusion compared with visual analysis.

Leslie WD, Tully SA, Yogendran MS, Ward LM, Nour KA, Metge CJ.

Nucl Med Commun. 2004 Aug;25(8):833-8.

PMID:
15266179
35.
36.

An examination of the effect of cytochrome P450 drug interactions of hydroxymethylglutaryl-coenzyme A reductase inhibitors on health care utilization: a Canadian population-based study.

Einarson TR, Metge CJ, Iskedjian M, Mukherjee J.

Clin Ther. 2002 Dec;24(12):2126-36. Erratum in: Clin Ther. 2003 Dec;25(12):3190.

PMID:
12581550
37.

Use of pharmaceuticals by inflammatory bowel disease patients: a population-based study.

Metge CJ, Blanchard JF, Peterson S, Bernstein CN.

Am J Gastroenterol. 2001 Dec;96(12):3348-55.

PMID:
11774948
38.

Antibiotic use in a Canadian Province, 1995-1998.

Carrie AG, Metge CJ, Zhanel GG.

Ann Pharmacother. 2000 Apr;34(4):459-64.

PMID:
10772430
39.

Inter- and intrarater reliability of retrospective drug utilization reviewers.

Zuckerman IH, Mulhearn DM, Metge CJ.

J Am Pharm Assoc (Wash). 1999 Jan-Feb;39(1):45-9.

PMID:
9990187
40.

The impaired pharmacist. Setting up a program: how one group went about it.

Metge CJ, Brown PA.

Am Pharm. 1985 Jun;NS25(6):49-51. No abstract available.

PMID:
4025138

Supplemental Content

Loading ...
Support Center